ICL Files Annual Report for 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy ICL?
Source: Newsfilter
- Annual Report Submission: ICL filed its Form 20-F for the fiscal year 2025 with the SEC on March 11, 2026, reporting revenues exceeding $7 billion, indicating sustained growth potential in agriculture, food, and industrial solutions.
- Shareholder Information Access: Shareholders can request free copies of the complete audited financial statements from the Investor Relations department, ensuring transparency and enhancing investor confidence, which fosters a positive relationship between the company and its shareholders.
- Global Business Overview: ICL employs over 12,000 individuals globally, focusing on driving long-term growth through its specialty agriculture and food businesses while effectively managing its bromine, potash, and phosphate mineral resources to address sustainability challenges related to food security and mineral access.
- Risk Factors Advisory: The announcement highlights various potential risks, including the security situation in Israel, market volatility, and environmental regulations, which could impact the company's operations and financial performance, urging investors to carefully assess these risks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ICL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ICL
Wall Street analysts forecast ICL stock price to rise
3 Analyst Rating
0 Buy
3 Hold
0 Sell
Hold
Current: 5.340
Low
5.80
Averages
6.18
High
6.75
Current: 5.340
Low
5.80
Averages
6.18
High
6.75
About ICL
ICL Group Ltd, formerly known as Israel Chemicals Ltd, is an Israel-based company, which is engaged in the fertilizer and specialty chemical sectors. The Company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from different sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus, elemental bromine, and other chemicals. The Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
ICL Files Annual Report for 2025
- Annual Report Submission: ICL filed its Form 20-F for the fiscal year 2025 with the SEC on March 11, 2026, reporting revenues exceeding $7 billion, indicating sustained growth potential in agriculture, food, and industrial solutions.
- Shareholder Information Access: Shareholders can request free copies of the complete audited financial statements from the Investor Relations department, ensuring transparency and enhancing investor confidence, which fosters a positive relationship between the company and its shareholders.
- Global Business Overview: ICL employs over 12,000 individuals globally, focusing on driving long-term growth through its specialty agriculture and food businesses while effectively managing its bromine, potash, and phosphate mineral resources to address sustainability challenges related to food security and mineral access.
- Risk Factors Advisory: The announcement highlights various potential risks, including the security situation in Israel, market volatility, and environmental regulations, which could impact the company's operations and financial performance, urging investors to carefully assess these risks.
See More
ICL Group Appoints New CFO Asaf Alperovitz
- Executive Change: ICL Group announced the appointment of Asaf Alperovitz as CFO, effective June 15, 2026, succeeding retiring Aviram Lahav, indicating a strategic shift in leadership to support future growth.
- Rich Financial Background: Currently CFO at SolarEdge Technologies, Alperovitz has held CFO roles at Delta Galil Industries and Syneron Candela, bringing extensive financial management experience that will enhance ICL's operational efficiency in future financial strategies.
- Future Outlook: ICL Group targets an EBITDA of $1.4B to $1.6B in 2026, reflecting a proactive stance in advancing specialty growth engines and portfolio realignment, with Alperovitz's expertise expected to facilitate achieving these goals.
- Market Reaction: This executive change may influence investor confidence in ICL's future financial performance, particularly during a critical period of strategic restructuring, where Alperovitz's experience will be vital for the company's stable growth.
See More
ICL Group Appoints New CFO Asaf Alperovitz
- Executive Transition: ICL Group announced that Asaf Alperovitz will succeed Aviram Lahav as Chief Financial Officer on June 15, 2026, marking a significant leadership change aimed at advancing the company's strategic development.
- Leadership Experience: Alperovitz brings over 20 years of financial management experience, having served as CFO at SolarEdge Technologies and held executive roles at several prominent companies, which will provide ICL with new insights and expertise.
- Company Appreciation: ICL President Elad Aharonson expressed gratitude for Lahav's contributions, highlighting his significant role in the company's growth, reflecting the company's commitment to talent and confidence in the future.
- Strategic Outlook: Alperovitz's appointment is seen as a crucial step in executing ICL's growth strategy, expected to enhance the company's business expansion and market competitiveness through his global experience and management skills.
See More
S&P 500 Futures Decline in Pre-Market Trading; Jazz Pharmaceuticals and Live Nation Entertainment at the Forefront
Market Opening: U.S. stock markets are set to open in two hours.
Jazz Pharmaceuticals Performance: Jazz Pharmaceuticals PLC (JAZZ) saw a 10.7% increase in pre-market trading.
Live Nation Entertainment Performance: Live Nation Entertainment Inc. (LYV) experienced an 8.9% rise in pre-market trading.
Overall Market Sentiment: The pre-market gains indicate positive sentiment among investors for these companies.
See More
ICL Group Reports Strong Q4 2025 Earnings and Strategic Developments
- Strong Financial Performance: ICL Group reported Q4 2025 sales of $1.701 billion, a 6% year-over-year increase, with all four business segments showing growth, indicating robust market performance and ongoing business resilience.
- Significant EBITDA Growth: The adjusted EBITDA for Q4 was $380 million, reflecting a 10% year-over-year improvement, which not only highlights the company's successful transition in specialty crop nutrition and food solutions but also lays a solid foundation for future investments and shareholder returns.
- Strategic Acquisition and Adjustments: The acquisition of Bartek Ingredients, a global leader in food-grade malic and fumaric acids, alongside the discontinuation of LFP battery material projects in the U.S. and Spain, demonstrates ICL's commitment to optimizing its portfolio and focusing on high-growth areas.
- Optimistic Future Outlook: Management anticipates consolidated EBITDA for 2026 to be between $1.4 billion and $1.6 billion, with potash sales volumes expected to reach 4.5 to 4.7 million metric tons, reflecting confidence in ongoing operational improvements and market demand.
See More
ICL Group Declares $0.0465 Quarterly Dividend with 3.22% Yield
- Quarterly Dividend Announcement: ICL Group has declared a quarterly dividend of $0.0465 per share, reflecting a forward yield of 3.22%, which underscores the company's ongoing commitment to stable cash flow and shareholder returns.
- Dividend Payment Schedule: The dividend is set to be paid on March 25, with a record date of March 10 and an ex-dividend date also on March 10, ensuring shareholders receive their earnings promptly, thereby boosting investor confidence.
- Stable Financial Performance: In its latest earnings report, ICL Group reported a non-GAAP EPS of $0.09 and revenue of $1.7 billion, indicating robust performance and profitability within the market.
- Future Outlook: The company has initiated its outlook for FY26, demonstrating a positive attitude towards future growth, which may attract more investor interest in its long-term development potential.
See More
ICL Files Annual Report for 2025
- Annual Report Submission: ICL filed its Form 20-F for the fiscal year 2025 with the SEC on March 11, 2026, reporting revenues exceeding $7 billion, indicating sustained growth potential in agriculture, food, and industrial solutions.
- Shareholder Information Access: Shareholders can request free copies of the complete audited financial statements from the Investor Relations department, ensuring transparency and enhancing investor confidence, which fosters a positive relationship between the company and its shareholders.
- Global Business Overview: ICL employs over 12,000 individuals globally, focusing on driving long-term growth through its specialty agriculture and food businesses while effectively managing its bromine, potash, and phosphate mineral resources to address sustainability challenges related to food security and mineral access.
- Risk Factors Advisory: The announcement highlights various potential risks, including the security situation in Israel, market volatility, and environmental regulations, which could impact the company's operations and financial performance, urging investors to carefully assess these risks.
See More
ICL Group Appoints New CFO Asaf Alperovitz
- Executive Change: ICL Group announced the appointment of Asaf Alperovitz as CFO, effective June 15, 2026, succeeding retiring Aviram Lahav, indicating a strategic shift in leadership to support future growth.
- Rich Financial Background: Currently CFO at SolarEdge Technologies, Alperovitz has held CFO roles at Delta Galil Industries and Syneron Candela, bringing extensive financial management experience that will enhance ICL's operational efficiency in future financial strategies.
- Future Outlook: ICL Group targets an EBITDA of $1.4B to $1.6B in 2026, reflecting a proactive stance in advancing specialty growth engines and portfolio realignment, with Alperovitz's expertise expected to facilitate achieving these goals.
- Market Reaction: This executive change may influence investor confidence in ICL's future financial performance, particularly during a critical period of strategic restructuring, where Alperovitz's experience will be vital for the company's stable growth.
See More
ICL Group Appoints New CFO Asaf Alperovitz
- Executive Transition: ICL Group announced that Asaf Alperovitz will succeed Aviram Lahav as Chief Financial Officer on June 15, 2026, marking a significant leadership change aimed at advancing the company's strategic development.
- Leadership Experience: Alperovitz brings over 20 years of financial management experience, having served as CFO at SolarEdge Technologies and held executive roles at several prominent companies, which will provide ICL with new insights and expertise.
- Company Appreciation: ICL President Elad Aharonson expressed gratitude for Lahav's contributions, highlighting his significant role in the company's growth, reflecting the company's commitment to talent and confidence in the future.
- Strategic Outlook: Alperovitz's appointment is seen as a crucial step in executing ICL's growth strategy, expected to enhance the company's business expansion and market competitiveness through his global experience and management skills.
See More
S&P 500 Futures Decline in Pre-Market Trading; Jazz Pharmaceuticals and Live Nation Entertainment at the Forefront
Market Opening: U.S. stock markets are set to open in two hours.
Jazz Pharmaceuticals Performance: Jazz Pharmaceuticals PLC (JAZZ) saw a 10.7% increase in pre-market trading.
Live Nation Entertainment Performance: Live Nation Entertainment Inc. (LYV) experienced an 8.9% rise in pre-market trading.
Overall Market Sentiment: The pre-market gains indicate positive sentiment among investors for these companies.
See More
ICL Group Reports Strong Q4 2025 Earnings and Strategic Developments
- Strong Financial Performance: ICL Group reported Q4 2025 sales of $1.701 billion, a 6% year-over-year increase, with all four business segments showing growth, indicating robust market performance and ongoing business resilience.
- Significant EBITDA Growth: The adjusted EBITDA for Q4 was $380 million, reflecting a 10% year-over-year improvement, which not only highlights the company's successful transition in specialty crop nutrition and food solutions but also lays a solid foundation for future investments and shareholder returns.
- Strategic Acquisition and Adjustments: The acquisition of Bartek Ingredients, a global leader in food-grade malic and fumaric acids, alongside the discontinuation of LFP battery material projects in the U.S. and Spain, demonstrates ICL's commitment to optimizing its portfolio and focusing on high-growth areas.
- Optimistic Future Outlook: Management anticipates consolidated EBITDA for 2026 to be between $1.4 billion and $1.6 billion, with potash sales volumes expected to reach 4.5 to 4.7 million metric tons, reflecting confidence in ongoing operational improvements and market demand.
See More
ICL Group Declares $0.0465 Quarterly Dividend with 3.22% Yield
- Quarterly Dividend Announcement: ICL Group has declared a quarterly dividend of $0.0465 per share, reflecting a forward yield of 3.22%, which underscores the company's ongoing commitment to stable cash flow and shareholder returns.
- Dividend Payment Schedule: The dividend is set to be paid on March 25, with a record date of March 10 and an ex-dividend date also on March 10, ensuring shareholders receive their earnings promptly, thereby boosting investor confidence.
- Stable Financial Performance: In its latest earnings report, ICL Group reported a non-GAAP EPS of $0.09 and revenue of $1.7 billion, indicating robust performance and profitability within the market.
- Future Outlook: The company has initiated its outlook for FY26, demonstrating a positive attitude towards future growth, which may attract more investor interest in its long-term development potential.
See More
